- Home
- SORA vs INO Comparison
SORA vs INO Comparison
Compare SORA & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SORA | INO |
|---|---|---|
| Founded | 2001 | 1979 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 131.0M | 136.6M |
| IPO Year | 2025 | 1998 |
Fundamental Metrics
Financial Performance| Metric | SORA | INO |
|---|---|---|
| Price | $3.17 | $1.70 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 9.5K | ★ 1.8M |
| Earning Date | 05-12-2026 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $14,081,504.00 | $182,337.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $21,214.02 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.80 | $1.30 |
| 52 Week High | $14.15 | $2.98 |
Technical Indicators
Market Signals| Indicator | SORA | INO |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 36.15 |
| Support Level | N/A | $1.68 |
| Resistance Level | N/A | $1.86 |
| Average True Range (ATR) | 0.00 | 0.19 |
| MACD | 0.00 | -0.06 |
| Stochastic Oscillator | 0.00 | 3.30 |
Price Performance
Historical ComparisonAbout SORA Top Win International Limited Ordinary Shares
AsiaStrategy is a wholesaler engaged in trading, distribution, and retail of luxury watches of international brands. The Group sources its luxury watches from Europe, Singapore, Japan, and Hong Kong, then sells the goods to retail sellers and other distributors in the watch industry.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.